{"title": "Novavax, at long last, clinches FDA emergency nod for protein-based COVID shot", "author": "Fraiser Kansteiner", "url": "https://www.fiercepharma.com/pharma/novavax-long-last-clinches-fda-emergency-nod-protein-based-covid-shot", "hostname": "fiercepharma.com", "description": "It's official: A new COVID-19 vaccine will soon be on tap in the U.S. | Late Wednesday, the FDA gave the all-clear to Novavax's protein-based shot, teeing up the nation's fourth pandemic prophylactic behind those from Pfizer-BioNTech, Moderna and Johnson & Johnson.", "sitename": "FiercePharma", "date": "2022-07-13", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}